526
Views
4
CrossRef citations to date
0
Altmetric
REVIEW

Melatonin Treatment for Pediatric Patients with Insomnia: Is There a Place for It?

, &
Pages 1927-1944 | Received 16 Jun 2022, Accepted 18 Sep 2022, Published online: 27 Oct 2022

References

  • Meltzer LJ, Williamson AA, Mindell JA. Pediatric sleep health: it matters, and so does how we define it. Sleep Med Rev. 2021;57:101425. doi:10.1016/j.smrv.2021.101425
  • Hirshkowitz M, Whiton K, Albert SM, et al. National Sleep Foundation’s updated sleep duration recommendations: final report. Sleep Health. 2015;1(4):233–243. doi:10.1016/j.sleh.2015.10.004
  • Meltzer LJ, Plaufcan MR, Thomas JH, Mindell JA. Sleep problems and sleep disorders in pediatric primary care: treatment recommendations, persistence, and health care utilization. J Clin Sleep Med JCSM off Publ Am Acad Sleep Med. 2014;10(4):421–426. doi:10.5664/jcsm.3620
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth ed. American Psychiatric Association; 2013. doi:10.1176/appi.books.9780890425596
  • American Academy of Sleep Medicine. International Classification of Sleep Disorders; 2014.
  • Dionne G, Touchette E, Forget-Dubois N, et al. Associations between sleep-wake consolidation and language development in early childhood: a longitudinal twin study. Sleep. 2011;34(8):987–995. doi:10.5665/SLEEP.1148
  • Beebe DW. Cognitive, behavioral, and functional consequences of inadequate sleep in children and adolescents. Pediatr Clin. 2011;58(3):649–665.
  • Owens J. Adolescent Sleep Working Group, Committee on Adolescence. Insufficient sleep in adolescents and young adults: an update on causes and consequences. Pediatrics. 2014;134(3):e921–932. doi:10.1542/peds.2014-1696
  • Ai L, et al. The Developmental Course of Sleep Disturbances Across Childhood Relates to Brain Morphology at Age 7: the Generation R Study. Sleep. 2017;40:1. doi:10.1093/sleep/zsw022
  • Magee L, Hale L. Longitudinal associations between sleep duration and subsequent weight gain: a systematic review. Sleep Med Rev. 2012;16(3):231–241. doi:10.1016/j.smrv.2011.05.005
  • Winsler A, Deutsch A, Vorona RD, Payne PA, Szklo-Coxe M. Sleepless in Fairfax: the difference one more hour of sleep can make for teen hopelessness, suicidal ideation, and substance use. J Youth Adolesc. 2015;44(2):362–378. doi:10.1007/s10964-014-0170-3
  • Wong MM, Brower KJ, Zucker RA. Sleep problems, suicidal ideation, and self-harm behaviors in adolescence. J Psychiatr Res. 2011;45(4):505–511. doi:10.1016/j.jpsychires.2010.09.005
  • Meltzer LJ, Mindell JA. Relationship between child sleep disturbances and maternal sleep, mood, and parenting stress: a pilot study. J Fam Psychol JFP J Div Fam Psychol Am Psychol Assoc Div. 2007;21(1):67–73. doi:10.1037/0893-3200.21.1.67
  • Cook F, Conway LJ, Giallo R, Gartland D, Sciberras E, Brown S. Infant sleep and child mental health: a longitudinal investigation. Arch Dis Child. 2020;105(7):655–660. doi:10.1136/archdischild-2019-318014
  • Meltzer LJ, Wainer A, Engstrom E, Pepa L, Mindell JA. Seeing the Whole Elephant: a scoping review of behavioral treatments for pediatric insomnia. Sleep Med Rev. 2021;56:101410. doi:10.1016/j.smrv.2020.101410
  • Hartz I, Handal M, Tverdal A, Skurtveit S. Paediatric Off-Label Use of Melatonin – a Register Linkage Study between the Norwegian Prescription Database and Patient Register. Basic Clin Pharmacol Toxicol. 2015;117(4):267–273. doi:10.1111/bcpt.12411
  • Hartz I, Furu K, Bratlid T, Handal M, Skurtveit S. Hypnotic drug use among 0–17 year olds during 2004–2011: a nationwide prescription database study. Scand J Public Health. 2012;40(8):704–711. doi:10.1177/1403494812464446
  • Braüner JV, Johansen LM, Roesbjerg T, Pagsberg AK. Off-Label Prescription of Psychopharmacological Drugs in Child and Adolescent Psychiatry. J Clin Psychopharmacol. 2016;36(5):500–507. doi:10.1097/JCP.0000000000000559
  • Bock DE, Roach-Fox E, Seabrook JA, Rieder MJ, Matsui D. Sleep-promoting medications in children: physician prescribing habits in Southwestern Ontario, Canada. Sleep Med. 2016;17:52–56. doi:10.1016/j.sleep.2015.10.003
  • Nielsen ES, Rasmussen L, Hellfritzsch M, Thomsen PH, Nørgaard M, Laursen T. Trends in Off-Label Prescribing of Sedatives, Hypnotics and Antidepressants among Children and Adolescents – a Danish, Nationwide Register-Based Study. Basic Clin Pharmacol Toxicol. 2017;120(4):360–367. doi:10.1111/bcpt.12706
  • Efron D, Danchin MH, Cranswick NE, Gulenc A, Hearps S, Hiscock H. Medication prescribed by Australian paediatricians: psychotropics predominate. J Paediatr Child Health. 2017;53(10):957–962. doi:10.1111/jpc.13615
  • Procaccini DE, Kudchadkar SR. Melatonin Administration Patterns for Pediatric Inpatients in a Tertiary Children’s Hospital. Hosp Pediatr. 2021;11(11):e308–e312. doi:10.1542/hpeds.2021-006117
  • Kimland EE, Bardage C, Collin J, Järleborg A, Ljung R, Iliadou AN. Pediatric use of prescribed melatonin in Sweden 2006–2017: a register based study. Eur Child Adolesc Psychiatry. 2021;30(9):1339–1350. doi:10.1007/s00787-020-01598-1
  • Rivara S, Pala D, Bedini A, Spadoni G. Therapeutic uses of melatonin and melatonin derivatives: a patent review (2012 – 2014). Expert Opin Ther Pat. 2015;25(4):425–441. doi:10.1517/13543776.2014.1001739
  • Tordjman S, Chokron S, Delorme R, et al. Melatonin: pharmacology, Functions and Therapeutic Benefits. Curr Neuropharmacol. 2017;15(3):434–443. doi:10.2174/1570159X14666161228122115
  • Lalanne S, Fougerou-Leurent C, Anderson GM, et al. Melatonin: from pharmacokinetics to clinical use in autism spectrum disorder. Int J Mol Sci. 2021;22(3):1490. doi:10.3390/ijms22031490
  • Reiter RJ, Tan DX, Galano A. Melatonin: exceeding Expectations. Physiology. 2014;29(5):325–333. doi:10.1152/physiol.00011.2014
  • Claustrat B. Mélatonine: aspects biochimiques, physiologiques et pharmacologiques en relation avec les phénomènes rythmiques et le sommeil. Médecine Sommeil. 2020;17(3):177–194. doi:10.1016/j.msom.2019.12.187
  • Lewy AJ, Ahmed S, Jackson JML, Sack RL. Melatonin Shifts Human Circadian Rhythms According to a Phase-Response Curve. Chronobiol Int. 1992;9(5):380–392. doi:10.3109/07420529209064550
  • Zaidan R, Geoffriau M, Brun J, et al. Melatonin Is Able to Influence Its Secretion in Humans: description of a Phase-Response Curve. Neuroendocrinology. 1994;60(1):105–112. doi:10.1159/000126726
  • Claustrat B. Mélatonine et troubles du rythme veille-sommeil. Médecine Sommeil. 2009;6(1):12–24. doi:10.1016/j.msom.2009.02.001
  • Kräuchi K, Cajochen C, Pache M, Flammer J, Wirz‐Justice A. Thermoregulatory effects of melatonin in relation to sleepiness. Chronobiol Int. 2006;23(1–2):475–484. doi:10.1080/07420520500545854
  • Strassman RJ, Qualls CR, Lisansky EJ, Peake GT. Elevated rectal temperature produced by all-night bright light is reversed by melatonin infusion in men. J Appl Physiol. 1991;71(6):2178–2182. doi:10.1152/jappl.1991.71.6.2178
  • Smits MG, Nagtegaal EE, van der Heijden J, Coenen AM, Kerkhof GA. Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial. J Child Neurol. 2001;16(2):86–92. doi:10.1177/088307380101600204
  • Ivanenko A, Crabtree VM, Tauman R, Gozal D. Melatonin in children and adolescents with insomnia: a retrospective study. Clin Pediatr (Phila). 2003;42(1):51–58. doi:10.1177/000992280304200108
  • van der Heijden KB, Smits MG, van Someren EJW, Boudewijn Gunning W. Prediction of melatonin efficacy by pretreatment dim light melatonin onset in children with idiopathic chronic sleep onset insomnia. J Sleep Res. 2005;14(2):187–194. doi:10.1111/j.1365-2869.2005.00451.x
  • van Geijlswijk IM, van der Heijden KB, Egberts ACG, Korzilius HPLM, Smits MG. Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCT. Psychopharmacology. 2010;212(3):379–391. doi:10.1007/s00213-010-1962-0
  • Eckerberg B, Lowden A, Nagai R, Åkerstedt T. Melatonin treatment effects on adolescent students’ sleep timing and sleepiness in a placebo-controlled crossover study. Chronobiol Int. 2012;29(9):1239–1248. doi:10.3109/07420528.2012.719962
  • van Maanen A, Meijer AM, Smits MG, van der Heijden KB, Oort FJ. Effects of Melatonin and Bright Light Treatment in Childhood Chronic Sleep Onset Insomnia With Late Melatonin Onset: a Randomized Controlled Study. Sleep. 2017;40:2. doi:10.1093/sleep/zsw038
  • Smits MG, van Stel HF, van der Heijden K, Meijer AM, Coenen AML, Kerkhof GA. Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2003;42(11):1286–1293. doi:10.1097/01.chi.0000085756.71002.86
  • Di WL, Kadva A, Johnston A, Silman R. Variable Bioavailability of Oral Melatonin. N Engl J Med. 1997;336(14):1028–1029. doi:10.1056/NEJM199704033361418
  • Garfinkel D, Laudon M, Nof D, Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet Lond Engl. 1995;346(8974):541–544. doi:10.1016/s0140-6736(95)91382-3
  • EMA. Slenyto. European Medicines Agency; 2018. Available from: https://www.ema.europa.eu/en/medicines/human/EPAR/slenyto. Accessed May 31, 2022.
  • Bruni O, Angriman M, Calisti F, et al. Practitioner Review: treatment of chronic insomnia in children and adolescents with neurodevelopmental disabilities. J Child Psychol Psychiatry. 2018;59(5):489–508. doi:10.1111/jcpp.12812
  • Salanitro M, Wrigley T, Ghabra H, et al. Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2022;139:104723. doi:10.1016/j.neubiorev.2022.104723
  • Wei S, Smits MG, Tang X, et al. Efficacy and safety of melatonin for sleep onset insomnia in children and adolescents: a meta-analysis of randomized controlled trials. Sleep Med. 2020;68:1–8. doi:10.1016/j.sleep.2019.02.017
  • Mantle D, Smits M, Boss M, Miedema I, van Geijlswijk I. Efficacy and safety of supplemental melatonin for delayed sleep-wake phase disorder in children: an overview. Sleep Med X. 2020;2:100022. doi:10.1016/j.sleepx.2020.100022
  • Zisapel N. Assessing the potential for drug interactions and long term safety of melatonin for the treatment of insomnia in children with autism spectrum disorder. Expert Rev Clin Pharmacol. 2022;15(2):175–185. doi:10.1080/17512433.2022.2053520
  • Malow BA, Findling RL, Schroder CM, et al. Sleep, Growth, and Puberty After 2 Years of Prolonged-Release Melatonin in Children With Autism Spectrum Disorder. J Am Acad Child Adolesc Psychiatry. 2021;60(2):252–261.e3. doi:10.1016/j.jaac.2019.12.007
  • Yuge K, Nagamitsu S, Ishikawa Y, et al. Long-term melatonin treatment for the sleep problems and aberrant behaviors of children with neurodevelopmental disorders. BMC Psychiatry. 2020;20(1):445. doi:10.1186/s12888-020-02847-y
  • Zwart TC, Smits MG, Egberts TCG, Rademaker CMA, van Geijlswijk IM. Long-Term Melatonin Therapy for Adolescents and Young Adults with Chronic Sleep Onset Insomnia and Late Melatonin Onset: evaluation of Sleep Quality, Chronotype, and Lifestyle Factors Compared to Age-Related Randomly Selected Population Cohorts. Healthc Basel Switz. 2018;6(1):E23. doi:10.3390/healthcare6010023
  • McDonagh MS, Holmes R, Hsu F. Pharmacologic Treatments for Sleep Disorders in Children: a Systematic Review. J Child Neurol. 2019;34(5):237–247. doi:10.1177/0883073818821030
  • Boafo A, Greenham S, Alenezi S, et al. Could long-term administration of melatonin to prepubertal children affect timing of puberty? A clinician’s perspective. Nat Sci Sleep. 2019;11:1–10. doi:10.2147/NSS.S181365
  • Erland LAE, Saxena PK. Melatonin Natural Health Products and Supplements: presence of Serotonin and Significant Variability of Melatonin Content. J Clin Sleep Med JCSM off Publ Am Acad Sleep Med. 2017;13(2):275–281. doi:10.5664/jcsm.6462
  • van Geijlswijk IM, Mol RH, Egberts TCG, Smits MG. Evaluation of sleep, puberty and mental health in children with long-term melatonin treatment for chronic idiopathic childhood sleep onset insomnia. Psychopharmacology. 2011;216(1):111–120. doi:10.1007/s00213-011-2202-y
  • Hoebert M, Van Der Heijden KB, Van Geijlswijk IM, Smits MG. Long-term follow-up of melatonin treatment in children with ADHD and chronic sleep onset insomnia. J Pineal Res. 2009;47(1):1–7. doi:10.1111/j.1600-079X.2009.00681.x
  • Carr R, Wasdell MB, Hamilton D, et al. Long-term effectiveness outcome of melatonin therapy in children with treatment-resistant circadian rhythm sleep disorders. J Pineal Res. 2007;43(4):351–359. doi:10.1111/j.1600-079X.2007.00485.x
  • Besag F, Vasey MJ, Lao KS, Wong IC. Adverse events associated with melatonin for the treatment of primary or secondary sleep disorders: a systematic review. CNS Drugs. 2019;33(12):1167–1186. doi:10.1007/s40263-019-00680-w
  • Foley HM, Steel AE. Adverse events associated with oral administration of melatonin: a critical systematic review of clinical evidence. Complement Ther Med. 2019;42:65–81. doi:10.1016/j.ctim.2018.11.003
  • Andersen LPH, Gögenur I, Rosenberg J, Reiter RJ. The safety of melatonin in humans. Clin Drug Investig. 2016;36(3):169–175. doi:10.1007/s40261-015-0368-5
  • Seabra MD, Bignotto M. Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res. 2000;29(4):193–200. doi:10.1034/j.1600-0633.2002.290401.x
  • Menczel Schrire Z, Phillips CL, Chapman JL, et al. Safety of higher doses of melatonin in adults: a systematic review and meta-analysis. J Pineal Res. 2022;72(2):e12782. doi:10.1111/jpi.12782
  • Kennaway DJ. What do we really know about the safety and efficacy of melatonin for sleep disorders? Curr Med Res Opin. 2022;38(2):211–227. doi:10.1080/03007995.2021.2000714
  • Forrester MB. Melatonin exposures reported to Texas poison centers in 1998-2003. Vet Hum Toxicol. 2004;46(6):345–346.
  • Gringras P, Nir T, Breddy J, Frydman-Marom A, Findling RL. Efficacy and Safety of Pediatric Prolonged-Release Melatonin for Insomnia in Children With Autism Spectrum Disorder. J Am Acad Child Adolesc Psychiatry. 2017;56(11):948–957.e4. doi:10.1016/j.jaac.2017.09.414
  • Bliddal M, Kildegaard H, Rasmussen L, et al. Melatonin use among children, adolescents, and young adults: a Danish nationwide drug utilization study. Eur Child Adolesc Psychiatry. 2022;1:1–9.
  • Tedroff K, von Euler M, Dahlén E. Melatonin usage in children and young adults, a registry-based cohort study. Eur J Paediatr Neurol. 2022;39:30–34. doi:10.1016/j.ejpn.2022.05.007
  • Hong YG, Riegler JL. Is melatonin associated with the development of autoimmune hepatitis? J Clin Gastroenterol. 1997;25(1):376–378. doi:10.1097/00004836-199707000-00020
  • Bardazzi F, Placucci F, Neri I, D’Antuono A, Patrizi A. Fixed drug eruption due to melatonin. Acta Derm Venereol. 1998;78(1):69–70. doi:10.1080/00015559850135913
  • Skrzelowski M, Brookhaus A, Shea LA, Berlau DJ. Melatonin Use in Pediatrics: evaluating the Discrepancy in Evidence Based on Country and Regulations Regarding Production. J Pediatr Pharmacol Ther. 2021;26(1):4–20. doi:10.5863/1551-6776-26.1.4
  • Zeidan J, Fombonne E, Scorah J, et al. Global prevalence of autism: a systematic review update. Autism Res off J Int Soc Autism Res. 2022;15(5):778–790. doi:10.1002/aur.2696
  • Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet Lond Engl. 2014;383(9920):896–910. doi:10.1016/S0140-6736(13)61539-1
  • Lai MC, Kassee C, Besney R, et al. Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6(10):819–829. doi:10.1016/S2215-0366(19)30289-5
  • Elrod MG, Nylund CM, Susi AL, et al. Prevalence of diagnosed sleep disorders and related diagnostic and surgical procedures in children with autism spectrum disorders. J Dev Behav Pediatr. 2016;37(5):377–384. doi:10.1097/DBP.0000000000000248
  • Combs D, Goodwin JL, Quan SF, Morgan WJ, Shetty S, Parthasarathy S. Insomnia, health-related quality of life and health outcomes in children: a seven year longitudinal cohort. Sci Rep. 2016;6(1):1–10. doi:10.1038/srep27921
  • Krakowiak P, Goodlin-Jones B, Hertz-Picciotto I, Croen LA, Hansen RL. Sleep problems in children with autism spectrum disorders, developmental delays, and typical development: a population-based study. J Sleep Res. 2008;17(2):197–206. doi:10.1111/j.1365-2869.2008.00650.x
  • Díaz-Román A, Zhang J, Delorme R, Beggiato A, Cortese S. Sleep in youth with autism spectrum disorders: systematic review and meta-analysis of subjective and objective studies. Evid Based Ment Health. 2018;21(4):146–154. doi:10.1136/ebmental-2018-300037
  • Geoffray MM, Nicolas A, Speranza M, Georgieff N. Are circadian rhythms new pathways to understand Autism Spectrum Disorder? J Physiol-Paris. 2016;110(4):434–438. doi:10.1016/j.jphysparis.2017.06.002
  • Rossignol DA, Frye RE. Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol. 2011;53(9):783–792. doi:10.1111/j.1469-8749.2011.03980.x
  • Carmassi C, Palagini L, Caruso D, et al. Systematic Review of Sleep Disturbances and Circadian Sleep Desynchronization in Autism Spectrum Disorder: toward an Integrative Model of a Self-Reinforcing Loop. Front Psychiatry. 2019;10. doi:10.3389/fpsyt.2019.00366
  • Maski K, Holbrook H, Manoach D, Hanson E, Kapur K, Stickgold R. Sleep Dependent Memory Consolidation in Children with Autism Spectrum Disorder. Sleep. 2015;38(12):1955–1963. doi:10.5665/sleep.5248
  • Veatch OJ, Sutcliffe JS, Warren ZE, Keenan BT, Potter MH, Malow BA. Shorter sleep duration is associated with social impairment and comorbidities in ASD. Autism Res off J Int Soc Autism Res. 2017;10(7):1221–1238. doi:10.1002/aur.1765
  • Cohen S, Conduit R, Lockley SW, Rajaratnam SM, Cornish KM. The relationship between sleep and behavior in autism spectrum disorder (ASD): a review. J Neurodev Disord. 2014;6(1):1–10. doi:10.1186/1866-1955-6-44
  • Mazurek MO, Sohl K. Sleep and Behavioral Problems in Children with Autism Spectrum Disorder. J Autism Dev Disord. 2016;46(6):1906–1915. doi:10.1007/s10803-016-2723-7
  • Sikora DM, Johnson K, Clemons T, Katz T. The relationship between sleep problems and daytime behavior in children of different ages with autism spectrum disorders. Pediatrics. 2012;130(Supplement_2):S83–S90. doi:10.1542/peds.2012-0900F
  • Taylor MA, Schreck KA, Mulick JA. Sleep disruption as a correlate to cognitive and adaptive behavior problems in autism spectrum disorders. Res Dev Disabil. 2012;33(5):1408–1417. doi:10.1016/j.ridd.2012.03.013
  • Mayes SD, Calhoun SL. Variables related to sleep problems in children with autism. Res Autism Spectr Disord. 2009;3(4):931–941. doi:10.1016/j.rasd.2009.04.002
  • Nguyen AKD, Murphy LE, Kocak M, Tylavsky FA, Pagani LS. Prospective Associations Between Infant Sleep at 12 Months and Autism Spectrum Disorder Screening Scores at 24 Months in a Community-Based Birth Cohort. J Clin Psychiatry. 2018;79(1):16m11127. doi:10.4088/JCP.16m11127
  • Mindell JA, Leichman ES, DuMond C, Sadeh A. Sleep and Social-Emotional Development in Infants and Toddlers. J Clin Child Adolesc Psychol off J Soc Clin Child Adolesc Psychol Am Psychol Assoc Div. 2017;46(2):236–246. doi:10.1080/15374416.2016.1188701
  • May T, Cornish K, Conduit R, Rajaratnam SMW, Rinehart NJ. Sleep in high-functioning children with autism: longitudinal developmental change and associations with behavior problems. Behav Sleep Med. 2015;13(1):2–18. doi:10.1080/15402002.2013.829064
  • Yavuz-Kodat E, Reynaud E, Geoffray MM, et al. Disturbances of Continuous Sleep and Circadian Rhythms Account for Behavioral Difficulties in Children with Autism Spectrum Disorder. J Clin Med. 2020;9(6):1978. doi:10.3390/jcm9061978
  • Mindell JA, Telofski LS, Wiegand B, Kurtz ES. A nightly bedtime routine: impact on sleep in young children and maternal mood. Sleep. 2009;32(5):599–606. doi:10.1093/sleep/32.5.599
  • Doo S, Wing YK. Sleep problems of children with pervasive developmental disorders: correlation with parental stress. Dev Med Child Neurol. 2006;48(8):650–655. doi:10.1017/S001216220600137X
  • Levin A, Scher A. Sleep Problems in Young Children with Autism Spectrum Disorders: a Study of Parenting Stress, Mothers’ Sleep-Related Cognitions, and Bedtime Behaviors. CNS Neurosci Ther. 2016;22(11):921–927. doi:10.1111/cns.12651
  • Polimeni M, Richdale A, Francis A. The impact of children’s sleep problems on the family and behavioural processes related to their development and maintenance. E-J Appl Psychol. 2007;3(1):):. doi:10.7790/ejap.v3i1.82
  • Pagan C, Delorme R, Callebert J, et al. The serotonin-N-acetylserotonin-melatonin pathway as a biomarker for autism spectrum disorders. Transl Psychiatry. 2014;4:e479. doi:10.1038/tp.2014.120
  • Tordjman S, Anderson GM, Pichard N, Charbuy H, Touitou Y. Nocturnal excretion of 6-sulphatoxymelatonin in children and adolescents with autistic disorder. Biol Psychiatry. 2005;57(2):134–138. doi:10.1016/j.biopsych.2004.11.003
  • Tordjman S, Anderson GM, Bellissant E, et al. Day and nighttime excretion of 6-sulphatoxymelatonin in adolescents and young adults with autistic disorder. Psychoneuroendocrinology. 2012;37(12):1990–1997. doi:10.1016/j.psyneuen.2012.04.013
  • Bourgeron T. From the genetic architecture to synaptic plasticity in autism spectrum disorder. Nat Rev Neurosci. 2015;16(9):551–563. doi:10.1038/nrn3992
  • Bourgeron T. The possible interplay of synaptic and clock genes in autism spectrum disorders. In: Cold Spring Harbor Symposia on Quantitative Biology. Vol. 72. Cold Spring Harbor Laboratory Press; 2007:645–654.
  • Yang Z, Matsumoto A, Nakayama K, et al. Circadian-relevant genes are highly polymorphic in autism spectrum disorder patients. Brain Dev. 2016;38(1):91–99. doi:10.1016/j.braindev.2015.04.006
  • Nicholas B, Rudrasingham V, Nash S, Kirov G, Owen MJ, Wimpory DC. Association of Per1 and Npas2 with autistic disorder: support for the clock genes/social timing hypothesis. Mol Psychiatry. 2007;12(6):581–592. doi:10.1038/sj.mp.4001953
  • Pagan C, Goubran-Botros H, Delorme R, et al. Disruption of melatonin synthesis is associated with impaired 14-3-3 and miR-451 levels in patients with autism spectrum disorders. Sci Rep. 2017;7(1):2096. doi:10.1038/s41598-017-02152-x
  • Melke J, Goubran Botros H, Chaste P, et al. Abnormal melatonin synthesis in autism spectrum disorders. Mol Psychiatry. 2008;13(1):90–98. doi:10.1038/sj.mp.4002016
  • Recommendations | autism spectrum disorder in under 19s: support and management | guidance | NICE. Available from: https://www.nice.org.uk/guidance/cg170/chapter/Recommendations. Accessed May 31, 2022.
  • Gringras P, Gamble C, Jones AP, et al. Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial. BMJ. 2012;345(nov05 1):e6664. doi:10.1136/bmj.e6664
  • Buckley AW, Hirtz D, Oskoui M, et al. Practice guideline: treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2020;94(9):392–404. doi:10.1212/WNL.0000000000009033
  • Howes OD, Rogdaki M, Findon JL, et al. Autism spectrum disorder: consensus guidelines on assessment, treatment and research from the British Association for Psychopharmacology. J Psychopharmacol. 2018;32(1):3–29. doi:10.1177/0269881117741766
  • Rasmussen L, Bilenberg N, Thomsen Ernst M, Abitz Boysen S, Pottegård A. Use of Psychotropic Drugs among Children and Adolescents with Autism Spectrum Disorders in Denmark: a Nationwide Drug Utilization Study. J Clin Med. 2018;7(10):339. doi:10.3390/jcm7100339
  • Parvataneni T, Srinivas S, Shah K, Patel RS. Perspective on Melatonin Use for Sleep Problems in Autism and Attention-Deficit Hyperactivity Disorder: a Systematic Review of Randomized Clinical Trials. Cureus. 2014;12(5):e8335. doi:10.7759/cureus.8335
  • Rzepka-Migut B, Paprocka J. Efficacy and Safety of Melatonin Treatment in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder—A Review of the Literature. Brain Sci. 2020;10(4):219. doi:10.3390/brainsci10040219
  • Abramova R, Campbell P, Baron J, Patel K, Parmar S. Review of Melatonin Supplementation for Sleep Disorders in Pediatric Special Populations. J Pharm Pract. 2020;33(4):533–539. doi:10.1177/0897190019845982
  • Abdelgadir IS, Gordon MA, Akobeng AK. Melatonin for the management of sleep problems in children with neurodevelopmental disorders: a systematic review and meta-analysis. Arch Dis Child. 2018;103(12):1155–1162. doi:10.1136/archdischild-2017-314181
  • Schroder CM, Malow BA, Maras A, et al. Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: impact on Child Behavior and Caregiver’s Quality of Life. J Autism Dev Disord. 2019;49(8):3218–3230. doi:10.1007/s10803-019-04046-5
  • Waldron AY, Spark MJ, Dennis CM. The Use of Melatonin by Children: parents’ Perspectives. J Clin Sleep Med. 2014;12(10):1395–1401. doi:10.5664/jcsm.6198
  • Breik N, Kuo I, Bugden S, Moffat M, Alessi-Severini S. Treating Children with ASD: the Perspective of Caregivers. J Pharm Pharm Sci. 2018;21(1s):74s–87s. doi:10.18433/jpps29829
  • Maras A, Schroder CM, Malow BA, et al. Long-term efficacy and safety of pediatric prolonged-release melatonin for insomnia in children with autism spectrum disorder. J Child Adolesc Psychopharmacol. 2018;28(10):699–710. doi:10.1089/cap.2018.0020
  • Roenneberg T, Kuehnle T, Juda M, et al. Epidemiology of the human circadian clock. Sleep Med Rev. 2007;11(6):429–438. doi:10.1016/j.smrv.2007.07.005
  • Dement W, Guilleminault C, Zarcone V. The pathologies of sleep: a case series approach. Nerv Syst. 1975;2:501–518.
  • Paine SJ, Fink J, Gander PH, Warman GR. Identifying advanced and delayed sleep phase disorders in the general population: a national survey of New Zealand adults. Chronobiol Int. 2014;31(5):627–636. doi:10.3109/07420528.2014.885036
  • Nesbitt AD. Delayed sleep-wake phase disorder. J Thorac Dis. 2018;10(Suppl 1):S103–S111. doi:10.21037/jtd.2018.01.11
  • Sivertsen B, Pallesen S, Stormark KM, Bøe T, Lundervold AJ, Hysing M. Delayed sleep phase syndrome in adolescents: prevalence and correlates in a large population based study. BMC Public Health. 2013;13:1163. doi:10.1186/1471-2458-13-1163
  • LeBlanc JC, Morehouse R, Rajda M, et al. Prevalence of delayed sleep phase syndrome in adolescents: a school-based survey. Pediatr Res. 1999;45(7):5. doi:10.1203/00006450-199904020-00035
  • Sivertsen B, Harvey AG, Pallesen S, Hysing M. Mental health problems in adolescents with delayed sleep phase: results from a large population-based study in Norway. J Sleep Res. 2015;24(1):11–18. doi:10.1111/jsr.12254
  • Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics. 2015;135(4):e994–1001. doi:10.1542/peds.2014-3482
  • Polanczyk GV, Willcutt EG, Salum GA, Kieling C, Rohde LA. ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. Int J Epidemiol. 2014;43(2):434–442. doi:10.1093/ije/dyt261
  • Cortese S, Faraone SV, Konofal E, Lecendreux M. Sleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studies. J Am Acad Child Adolesc Psychiatry. 2009;48(9):894–908. doi:10.1097/CHI.0b013e3181ac09c9
  • Konofal E, Lecendreux M, Cortese S. Sleep and ADHD. Sleep Med. 2010;11(7):652–658. doi:10.1016/j.sleep.2010.02.012
  • Konofal E, Lecendreux M, Deron J, et al. Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol. 2008;38(1):20–26. doi:10.1016/j.pediatrneurol.2007.08.014
  • Van der Heijden KB, Smits MG, Van Someren EJW, Gunning WB. Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: a circadian rhythm sleep disorder. Chronobiol Int. 2005;22(3):559–570. doi:10.1081/CBI-200062410
  • Auger RR, Burgess HJ, Emens JS, Deriy LV, Thomas SM, Sharkey KM. Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: an American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med JCSM off Publ Am Acad Sleep Med. 2015;11(10):1199–1236. doi:10.5664/jcsm.5100
  • Quera-Salva MA, Kilic-Huck U, Vecchierini MF. La mélatonine et son usage dans les troubles circadiens du rythme veille sommeil: recommandations de la société française de recherche et de médecine du sommeil (SFRMS). Médecine Sommeil. 2021;18(2):55–69. doi:10.1016/j.msom.2021.04.002
  • Mundey K, Benloucif S, Harsanyi K, Dubocovich ML, Zee PC. Phase-dependent treatment of delayed sleep phase syndrome with melatonin. Sleep. 2005;28(10):1271–1278. doi:10.1093/sleep/28.10.1271
  • Van der Heijden KB, Smits MG, Van Someren EJW, Ridderinkhof KR, Gunning WB. Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia. J Am Acad Child Adolesc Psychiatry. 2007;46(2):233–241. doi:10.1097/01.chi.0000246055.76167.0d
  • Weiss MD, Wasdell MB, Bomben MM, Rea KJ, Freeman RD. Sleep hygiene and melatonin treatment for children and adolescents with ADHD and initial insomnia. J Am Acad Child Adolesc Psychiatry. 2006;45(5):512–519. doi:10.1097/01chi.0000205706.78818.ef
  • Mohammadi MR, Mostafavi SA, Keshavarz SA, et al. Melatonin Effects in Methylphenidate Treated Children with Attention Deficit Hyperactivity Disorder: a Randomized Double Blind Clinical Trial. Iran J Psychiatry. 2012;7(2):87–92.
  • Goldman RD, Bongiorno PB, Olcese JM, Witt-Enderby PA, Shatkin JP. Myths and Evidence Regarding Melatonin Supplementation for Occasional Sleeplessness in the Pediatric Population. Pediatr Ann. 2021;50(9):e391–e395. doi:10.3928/19382359-20210823-01
  • Schröder CM, Broquère MA, Claustrat B, et al. Approches thérapeutiques des troubles du sommeil et des rythmes chez l’enfant avec TSA. L’Encéphale. 2022:S0013700621002177. doi:10.1016/j.encep.2021.08.005
  • Zisapel N. Melatonin and sleep. Open Neuroendocrinol J. 2010;3:85–95.
  • Wasdell MB, Jan JE, Bomben MM, et al. A randomized, placebo-controlled trial of controlled release melatonin treatment of delayed sleep phase syndrome and impaired sleep maintenance in children with neurodevelopmental disabilities. J Pineal Res. 2008;44(1):57–64. doi:10.1111/j.1600-079X.2007.00528.x
  • Appleton RE, Jones AP, Gamble C, et al. The use of MElatonin in children with neurodevelopmental disorders and impaired sleep: a randomised, double-blind, placebo-controlled, parallel study (MENDS). Health Technol Assess Winch Engl. 2012;16(40):i–239.
  • Chang TK, Chen J, Yang G, Yeung EY. Inhibition of procarcinogen‐bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin. J Pineal Res. 2010;48(1):55–64. doi:10.1111/j.1600-079X.2009.00724.x
  • Buckley AW, Hirtz D, Oskoui M, et al. Practice guideline: treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2020;94(9):392–404. doi:10.1212/WNL.0000000000009033